Kapelle Apotheek
ActiveKapelle Apotheek has been active since 2012 and the Belgian State Gazette contains no insolvency or warning signals. The 2024 annual accounts show equity of €122k and a net result of €97k. The figures fluctuate too strongly year-on-year for a reliable trend projection. Its solvency ranks better than 30% of 9623 sector peers (fiscal year 2024). The computed 12-month bankruptcy probability is 0.8% (low).
Checked score
Score 2024
64
/ 100
Healthy
The score weighs solvency, liquidity, profitability and financial development. Bankruptcy probability contributes 35%. Every signal that weighs is under Signals.
Axes · tick = 2023
Profitability91▼-3
Solvency47▲+16
Growth78=
Track record100
Bankruptcy probability, 12 months
0.8%
Low
0%0.5%1.5%4%10%≥ 25%
Credit up to €7k at 30 days acceptable
Liquidity tight (current ratio 1.31 against 1.09 in 2023; short-term debt: 74.4% and cash: 8.9% of total assets), and 78% of the assets are financed with debt.
Credit advice for your own amount and term
Signals
Four signals. The signal on the left, the evidence on the right.
−lowers risk+raises risk○neutral
raises risk · Higher-failure-rate sector
In this sector companies fail more often than the Belgian average.
Gazette · bankruptcies per sector, NACE 47
Relative position
BE, all sectors
reference
Sector 47
higher
← fewer bankruptcies
more bankruptcies →
lowers risk · Long track record
A company with a long track record statistically fails less often than a young one.
KBO · incorporation dateAge against the risk zone
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2024 was due by 31-07-2025 and was filed on 07-05-2025, 85 days ahead of the deadline.
NBB · 10 filingsDeviation from the deadline
2025
not confirmed
2024
85 d early
2023
23 d late
2022
11 d early
2021
1 d early
2020
32 d early
2019
36 d early
← before the deadline
after the deadline →
Financials · fiscal year 2024, abbreviated schema
Equity
€122k▲ 386%
2023 · €25k
2018: €6k
2019: €-20k
2020: €-38k
2021: €-65k
2022: €-52k
2023: €25k
2018 → 2024
Total assets
€554k▲ 43.6%
2023 · €386k
2018: €455k
2019: €395k
2020: €423k
2021: €343k
2022: €328k
2023: €386k
2018 → 2024
Net result
€97k▲ 25.2%
2023 · €77k
2018: €34k
2019: €-26k
2020: €-18k
2021: €-27k
2022: €13k
2023: €77k
2018 → 2024
Working capital
€129k▲ 324%
2023 · €31k
2018: €21k
2019: €-11k
2020: €-32k
2021: €-36k
2022: €-50k
2023: €31k
2018 → 2024
Multi-year overview
Every figure with its change against the year before
▲ rise
▼ fall
Line20202021202220232024Trend
Equity€-38k-€-65k▼ 71.0%€-52k▲ 19.9%€25k€122k▲ 386%
Operating result€-12k-€-19k▼ 50.7%€21k€96k▲ 367%€136k▲ 42.0%
Net result€-18k-€-27k▼ 51.1%€13k€77k▲ 497%€97k▲ 25.2%
Turnover and EBIT margin not published: the abbreviated schema does not require them.
Result per fiscal year
Operating resultNet result
After the dip in 2021 the operating result has climbed three years in a row; 2024 is 42% above 2023 and is the highest result in the available series.
Balance-sheet composition
2024 in colour, 2023 as the grey bar beneath
Assets €554k
Fixed assets
€13k▼ 3.4%
Current assets
€541k▲ 45.2%
Equity and liabilities €554k
Equity
€122k▲ 386%
Debt
€432k▲ 19.8%
The debt ratio falls from 93.5% to 78.0%. Equity and debt are higher.
Key figures and ratios
EBITDA
€139k▲
2023 · €113k
Cash flow
€99k▲
2023 · €94k
Solvency
22.0%▲
2023 · 6.5%
Current ratio
1.31▲
2023 · 1.09
Quick ratio
0.99▲
2023 · 0.72
Debt / equity
3.55▼
2023 · 14.40
ROE
79.4%▼
2023 · 308.3%
ROA
17.4%▼
2023 · 20.0%
Interest coverage
14.93▲
2023 · 10.63
Debt
€432k▲
2023 · €361k
Debt ≤ 1 year
€412k▲
2023 · €342k
Income taxes
€34k▲
2023 · €12k
Staff costs
€257k▼
2023 · €281k
Green means a favourable move, even when the figure itself falls: as with debt or debt / equity.
Filed annual accounts
As filed with the NBB · 2024 against 2023
Balance sheet
Code20232024
Assets
Total assets20/58€386k€554k▲
Fixed assets21/28€13k€13k▼
Intangible fixed assets21€0-
Tangible fixed assets22/27€13k€13k▼
Plant, machinery and equipment23€1k€850▼
Furniture and vehicles24€0-
Other tangible fixed assets26€12k€12k▲
Current assets29/58€373k€541k▲
Stocks and contracts in progress3€126k€134k▲
Stocks30/36€126k€134k▲
Amounts receivable within one year40/41€141k€325k▲
Trade receivables40€125k€235k▲
Other amounts receivable41€16k€89k▲
Cash at bank and in hand54/58€71k€49k▼
Deferred charges and accrued income490/1€35k€33k▼
Equity and liabilities
Total equity and liabilities10/49€386k€554k▲
Equity10/15€25k€122k▲
Contributions10/11€19k€19k=
Profit (loss) carried forward14€6k€103k▲
Amounts payable17/49€361k€432k▲
Amounts payable after more than one year17€0-
Financial debts170/4€0-
Amounts payable within one year42/48€342k€412k▲
Current portion of amounts payable after more than one year42€10k€40k▲
Trade debts44€160k€214k▲
Suppliers440/4€160k€214k▲
Advances received on contracts in progress46-€7k
Taxes, remuneration and social security45€51k€35k▼
Taxes450/3€8k€6k▼
Remuneration and social security454/9€42k€28k▼
Other amounts payable47/48€122k€116k▼
Accrued charges and deferred income492/3€18k€20k▲
Income statement
Code20232024
Remuneration, social security and pensions62€281k€257k▼
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€17k€2k▼
Other operating charges640/8€281€292▲
Gross operating margin9900€394k€396k▲
Operating profit (loss)9901€96k€136k▲
Financial income75/76B€4k€3k▼
Recurring financial income75€4k€3k▼
Financial charges65/66B€11k€9k▼
Recurring financial charges65€11k€9k▼
Profit (loss) for the period before taxes9903€90k€131k▲
Income taxes67/77€12k€34k▲
Profit (loss) for the period9904€77k€97k▲
Profit (loss) for the period to be appropriated9905€77k€97k▲
Appropriation of the result
Profit (loss) to be appropriated9906€6k€103k▲
Profit (loss) brought forward from the previous period14P€-71k€6k▲
Social balance
Average headcount (FTE)90874.04.0=
The notes to these accounts (10 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.
Timeline · acts, filings and financial milestones
2025
07-05
NBB filing
Annual accounts filed
fiscal year 2024 · abbreviated schema
2024
31-12
Financial
Highest result since 2018net €97k ▲25.2%
Operating result €136k, net result €97k, both a record.
31-12
Financial
Equity above €100kEq €122k ▲386%
3 profitable years in a row build equity to €122k.
23-08
NBB filing
Annual accounts filed
fiscal year 2023 · abbreviated schema · 23 days late
2023
20-07
NBB filing
Annual accounts filed
fiscal year 2022 · abbreviated schema
2022
31-12
Financial
Back to profitnet €13k
Net result €13k after 3 loss-making years.
30-07
NBB filing
Annual accounts filed
fiscal year 2021 · abbreviated schema
2021
31-12
Financial
Weakest financial yearnet €-27k
Net result drops to €-27k, the lowest in the series; recovery starts the following year.
29-06
NBB filing
Annual accounts filed
fiscal year 2020 · abbreviated schema
2020
25-06
NBB filing
Annual accounts filed
fiscal year 2019 · abbreviated schema
2019
18-06
NBB filing
Annual accounts filed
fiscal year 2018 · abbreviated schema
2018
19-06
NBB filing
Annual accounts filed
fiscal year 2017 · abbreviated schema
2017
18-07
NBB filing
Annual accounts filed
fiscal year 2016 · abbreviated schema
2016
25-07
NBB filing
Annual accounts filed
fiscal year 2015 · abbreviated schema
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
Directors · office · real estate
Directors
3 acts for this company are in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Aartselaar · 1 establishment unit since 2013
Cannot be placed on the map
This address could not be matched to a point in the Belgian address register (BOSA BEST). The address below comes straight from the Crossroads Bank.
Kapellestraat 902630 AartselaarGround area
386 m²
Building footprint
91 m²
Volume, LiDAR
31 m³
Parcel 11001B0281/00L000, Flanders · tallest building 8.7 m. Linked by address, not a title deed.
1 establishment unit
Kapelleapotheek // Kapelle Apotheek
since 20132.215.964.604
1 parcel
Flanders
1
(100%)
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 11001B0281/00L000 | Flanders | 386 m² | 1 · 91 m² | 8.7 m |
Linked by address, not proof of ownership
Methodology
via registered seat: 1
1 of 1 parcel with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.
Public money · subsidies and aid
Flemish government
2023 to 2025 · 3 entries · 2,269 EUR awarded · 2,269 EUR paid| Year | Entries | awarded | paid |
|---|---|---|---|
| 2025 | 2 | 2,149 EUR | 2,149 EUR |
| 2023 | 1 | 120 EUR | 120 EUR |
Schemes
Hinderpremie bij openbare werken
Subsidie voor opleiding en advies voor kmo's en zelfstandigen (kmo-portefeuille)
Recognitions · licences · registrations
Food safety, FASFC
1 siteAartselaar2.215.964.604
Similar companies · same sector, comparable size
PHARMAZINNES
BE 0734.679.978
Namur · Eq €122k
APOTHEEK TOLHUIS
BE 0413.595.528
Gent · Eq €122k
PHARMACIE SCHUBERT
BE 0447.095.269
Ukkel · Eq €122k
Global Pharma
BE 0769.932.847
Sint-Niklaas · Eq €122k
EUROPA APOTHEEK
BE 0827.020.614
Antwerpen · Eq €122k
Of 5,222 companies in sector 47730 we hold annual accounts for 3,861. 3,505 are within a factor 10 of this equity.See the whole sector
Company data · Crossroads Bank
Identification
Legal formPrivate limited company
Founded07-12-2012
Fiscal year end31-12
Trade name NL
24 Apotheek
Activities, NACEBEL
47730Retail sale of pharmaceutical products
Sources
Crossroads Bank for EnterprisesNational Bank · 12 filingsAddress and cadastre registers
Data from official sources, last processed on 22-09-2026. Scores and ratios are computed by Checked and are not a credit decision.
Contact details
1 entryPhone:038774911